Follow Us

References

Zostum 500 mg Injection

30_percentage_Mortality_Rate_Due_to_Anaerobic_Infections

30 % Mortality Rate Due to Anaerobic Infections

Download
38_Years_of_Unchanged_Efficacy_against_ESKAPE_and_Ananerobes

38 Years of Unchanged Efficacy against ESKAPE and Ananerobes

Download
70_Infectiuons_are_caused_by_Biofilm_Producing_pathogens

70% Infectiuons are caused by Biofilm Producing pathogens and CPZ-SLB is most effective against biofilm producing pathogenss

Download
CPZ_Vs_PIP-TAZO_70_percentage_Vs_60_percentage_in_Pneumonia

CPZ Vs PIP-TAZO (70% Vs 60%) in Pneumonia

Download
CPZ_Vs_Pipera_TAZO_against_CAP

CPZ Vs Pipera- TAZO against CAP

Download
CPZ-SLB_Best_Antibiotic_for_Surgical_Prophylaxis_80percentage_reduction_in_chances_of_Post_Surgical_Infections

CPZ-SLB Best Antibiotic for Surgical Prophylaxis (80% reduction in chances of Post Surgical Infections)

Download
CPZ_SLB_in_A.baumanii_associate_HAP

CPZ-SLB in A.baumanii associated HAP

Download
CPZ_SLB_in_Bacteremia

CPZ SLB in Bacteremia

Download
CPZ_SLB_IN_Febrile_Neutropenia

CPZ SLB IN Febrile Neutropenia

Download
CPZ-SLB-in-IAI-and-SSTI

CPZ SLB in IAI and SSTI

Download
CPZ_SLB_is_the_most_Effective_Antibiotic_in_Polymicrobial_DFI

CPZ-SLB is the most Effective Antibiotic in Polymicrobial DFI

Download
CPZ-SLB_offers_100_percentage_Efficacy_in_Obs_and_Gyn_Infections

CPZ-SLB offers 100% Efficacy in Obs & Gyn Infections

Download
CPZ-SLB_Preferred_Choice_for_SSI

CPZ-SLB Preferred Choice for SSI

Download
CPZ-SLB_Results_in_30_percentage_Mortality_reduction_in_Patients_with_VAP

CPZ-SLB Results in 30 percentage Mortality reduction in Patients with VAP

Download
CPZ-SLB Vs IMI-TAZO in A.baumanni indused Bacteremia

CPZ-SLB Results in 30 percentage Mortality reduction in Patients with VAP

Download
CPZ-SLB_Vs_PIP-TAZO_in_HAP_and_VAP

CPZ-SLB Vs IMI-TAZO in A.baumanni indused Bacteremia

Download
CPZ-SLB_Vs_PIP-TAZO_IN_RTI

CPZ-SLB Vs PIP-TAZO IN RTI

Download
Excellent_Susceptibility_of_CPZ-SLB_against_Bacterial_Infections_in_Fractures

Excellent Susceptibility of CPZ-SLB against Bacterial Infections in Fractures

Download
ICMR_Treatment_Guidelines_2019_Final

ICMR Treatment Guidelines 2019 Final

Download
Polymicrobial_infections_creating_difficulty_in_selecting_empiric_therapy

Polymicrobial infections creating difficulty in selecting empiric therapy

Download
Safety_Of_CPZ-SLB_in_Neonates_Day_3_Onwards

Safety Of CPZ-SLB in Neonates Day 3 Onwards

Download
Susceptibility_of_CPZ-SLB_Against_Various_Pthogens

Susceptibility of CPZ-SLB Against Various Pthogens

Download
Unsuccessful_Empiric_Therapy_is_due_to_resistance_amongst_Ananerobes

Unsuccessful Empiric Therapy is due to resistance amongst Ananerobes

Download